IBSP通过PI3 K/AKT途径促进清细胞细胞癌的进展
Zhen-Hua Jin1, Jun Ge2, Jin-Zhuo Ning3
1Department of Urology, Nantong Hospital of Traditional Chinese Medicine, Nantong, 226000, Jiangsu Province, P. R. China.
在清细胞细胞癌 (ccRCC) 中,IBSP过度表达,促进癌症生长和入侵. 抑制IBSP通过影响PI3K/AKT通路来抑制ccRCC的进展,这表明IBSP是治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 清细胞细胞癌 (ccRCC) 是一个重大的健康问题.
- 在ccRCC病变发生过程中,IBSP (Integrin-binding sialoprotein) 的作用在很大程度上仍未被探索.
- 确定ccRCC的新生物标志物和治疗点至关重要.
研究的目的:
- 为了研究cccRCC中的IBSP表达式.
- 阐明在ccRCC进展过程中IBSP的潜在机制.
- 评估IBSP作为ccRCC的潜在预后生物标志物和治疗点.
主要方法:
- 对IBSP表达和临床意义的TCGA数据集的分析.
- 在ccRCC组织中验证IBSP表达的西部抹杀和免疫组织化学.
- 在体外测试 (CCK-8,细胞亡,迁移,入侵) 来评估IBSP的功能作用.
- 西部涂抹检查PI3K/AKT通路激活.
主要成果:
- 与正常组织相比,在ccRCC组织中IBSP显著过度表达.
- 下调IBSP抑制了ccRCC细胞的增殖,迁移和入侵,同时在体外促进了细胞亡.
- 通过抑制PI3K/AKT酸化,IBSP下调抑制了ccRCC的生长,在体外和体内.
结论:
- 在ccRCC中,IBSP作为潜在的瘤基因起作用.
- IBSP是一个有前途的预后生物标志物和ccRCC的治疗目标.
- 针对IBSP,可能与PI3K/AKT抑制剂结合使用,可能改善ccRCC治疗结果.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Inhibition of Cdk Activity
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
